These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. Montalto M; Curigliano V; Santoro L; Lombardi M; Covino M; Cammarota G; Dalvai S; D'Onofrio F; Gasbarrini A; Gasbarrini G Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):965-7. PubMed ID: 16894309 [TBL] [Abstract][Full Text] [Related]
5. Non-steroidal anti-inflammatory drug induced injury to the small intestine. Tachecí I; Kopácová M; Rejchrt S; Bures J Acta Medica (Hradec Kralove); 2010; 53(1):3-11. PubMed ID: 20608226 [TBL] [Abstract][Full Text] [Related]
6. Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study. Montalto M; Gallo A; Curigliano V; D'Onofrio F; Santoro L; Covino M; Dalvai S; Gasbarrini A; Gasbarrini G Aliment Pharmacol Ther; 2010 Jul; 32(2):209-14. PubMed ID: 20384610 [TBL] [Abstract][Full Text] [Related]
7. A simple method for assessing intestinal inflammation in Crohn's disease. Tibble J; Teahon K; Thjodleifsson B; Roseth A; Sigthorsson G; Bridger S; Foster R; Sherwood R; Fagerhol M; Bjarnason I Gut; 2000 Oct; 47(4):506-13. PubMed ID: 10986210 [TBL] [Abstract][Full Text] [Related]
8. Assessment of ileal pouch inflammation by single-stool calprotectin assay. Thomas P; Rihani H; Røseth A; Sigthorsson G; Price A; Nicholls RJ; Bjarnason I Dis Colon Rectum; 2000 Feb; 43(2):214-20. PubMed ID: 10696896 [TBL] [Abstract][Full Text] [Related]
9. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Tibble JA; Sigthorsson G; Foster R; Forgacs I; Bjarnason I Gastroenterology; 2002 Aug; 123(2):450-60. PubMed ID: 12145798 [TBL] [Abstract][Full Text] [Related]
10. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma. Tibble J; Sigthorsson G; Foster R; Sherwood R; Fagerhol M; Bjarnason I Gut; 2001 Sep; 49(3):402-8. PubMed ID: 11511563 [TBL] [Abstract][Full Text] [Related]
11. The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy. Whitfield-Cargile CM; Cohen ND; Chapkin RS; Weeks BR; Davidson LA; Goldsby JS; Hunt CL; Steinmeyer SH; Menon R; Suchodolski JS; Jayaraman A; Alaniz RC Gut Microbes; 2016 May; 7(3):246-61. PubMed ID: 27007819 [TBL] [Abstract][Full Text] [Related]
12. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Olafsdottir E; Aksnes L; Fluge G; Berstad A Acta Paediatr; 2002; 91(1):45-50. PubMed ID: 11883817 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy. Simon O'Brien E; Robert A; Gauthier D; Le Cavorzin A; Planchais J; Roux X; Verleye M; Castagné V Benef Microbes; 2023 Sep; 14(3):239-253. PubMed ID: 37646075 [TBL] [Abstract][Full Text] [Related]
14. Fecal excretion of calprotectin in colorectal cancer: relationship to tumor characteristics. Kristinsson J; Armbruster CH; Ugstad M; Kriwanek S; Nygaard K; Tøn H; Fuglerud P Scand J Gastroenterol; 2001 Feb; 36(2):202-7. PubMed ID: 11252414 [TBL] [Abstract][Full Text] [Related]
15. Small intestinal injury in NSAID users suffering from rheumatoid arthritis or osteoarthritis. Tachecí I; Bradna P; Douda T; Baštecká D; Kopáčová M; Rejchrt S; Lutonský M; Soukup T; Bureš J Rheumatol Int; 2016 Nov; 36(11):1557-1561. PubMed ID: 27549792 [TBL] [Abstract][Full Text] [Related]
16. Fecal calprotectin: a significant step in the noninvasive assessment of intestinal inflammation. Bjarnason I; Sherwood R J Pediatr Gastroenterol Nutr; 2001 Jul; 33(1):11-3. PubMed ID: 11479401 [No Abstract] [Full Text] [Related]
17. Relationship between intestinal permeability and calprotectin concentration in gut lavage fluid. Berstad A; Arslan G; Folvik G Scand J Gastroenterol; 2000 Jan; 35(1):64-9. PubMed ID: 10672837 [TBL] [Abstract][Full Text] [Related]
18. A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. Maiden L; Thjodleifsson B; Theodors A; Gonzalez J; Bjarnason I Gastroenterology; 2005 May; 128(5):1172-8. PubMed ID: 15887101 [TBL] [Abstract][Full Text] [Related]
19. Is fecal calprotectin the next standard in inflammatory bowel disease activity tests? Alic M Am J Gastroenterol; 1999 Nov; 94(11):3370-1. PubMed ID: 10566749 [No Abstract] [Full Text] [Related]
20. Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy? Adebayo D; Bjarnason I Postgrad Med J; 2006 Mar; 82(965):186-91. PubMed ID: 16517800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]